Prenetics Global Limited
Prenetics Global Limited (PRE) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
pre · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Prenetics Global Limited (PRE) measures how much investors pay for each dollar of the company's trailing earnings. PRE's current PE ratio of N/A is calculated by dividing its stock price of $20.00 by its TTM earnings per share of -$3.64.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Prenetics Global LimitedYou PRE | $340M | N/A | — | -$3.64 |
 Armata Pharmaceuticals, Inc. ARMP | $278M | N/A | — | -$4.80 |
 Atlantic International Corp. ATLN | $61M | N/A | — | -$1.08 |
 Codexis, Inc. CDXS | $237M | N/A | — | -$0.50 |
 Insight Molecular Diagnostics Inc. IMDX | $154M | N/A | — | -$1.65 |
 MaxCyte, Inc. MXCT | $123M | N/A | — | -$0.42 |
 OraSure Technologies, Inc. OSUR | $286M | N/A | — | -$0.94 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-2.68 | — | |
2024-12-31 FY2024 | — | $-3.64 | — | |
2023-12-31 FY2023 | — | $-5.58 | — | |
2022-12-31 FY2022 | — | $-37.57 | — | |
2021-12-31 FY2021 | — | $-47.04 | — | |
2020-12-31 FY2020 | — | $-0.26 | — | |
2019-12-31 FY2019 | — | $-2.72 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Prenetics Global Limited (PRE) measures how much investors pay for each dollar of the company's trailing earnings. PRE's current PE ratio of N/A is calculated by dividing its stock price of $20.00 by its TTM earnings per share of -$3.64.
Frequently asked questions
PRE pe ratio · 6 questionsPRE's current PE ratio is N/A as of 2026-06-09, based on a stock price of $20.00 and TTM EPS of -$3.64. Data sourced from Financial Modeling Prep via PRE's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Prenetics Global Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09